3D Systems' second-quarter 2026 call carried two headlines: improving results signaling a recovery in additive manufacturing, and the launch of a CEO leadership-transition plan for Dr. Jeffrey Graves. Revenue rose 1.4% year-over-year (on an adjusted basis excluding 2025 software divestitures) to $94.6 million, but the underlying story was a return of customer capital spending: printer (hardware) sales jumped more than 45% year-over-year, led by the DMP 350 metal system (up ~90%) and the new SLA 825 polymer platform (up ~125%). Three of the four strategic focus markets -- med tech, aerospace and defense, and data center infrastructure -- each grew double digits, and the company booked its strongest industrial polymer order since 2014, a large multi-quarter order for printers used to produce reusable rockets. Healthcare, the largest segment, grew 6.8% to $48.1 million on med tech and NextDent denture-printer adoption, while the industrial segment declined 3.7% on legacy and non-core softness. Adjusted EBITDA improved notably to near breakeven, helped by roughly $60 million of run-rate cost reductions and $2.6 million of tariff refunds, though non-GAAP gross margin of 36.7% was pressured by a heavier hardware mix. Management guided to mid-single-digit sequential revenue growth but a small adjusted-EBITDA loss in Q3, and continues to guide only one quarter out given macro volatility. The path to profitability hinges on volume-driven margin expansion through high-margin polymer materials pull-through and metal-part production. Graves framed the transition as handing a well-positioned, refreshed, cash-rich company to a successor with a long runway, while remaining in the role for months during the search.
Hello. Welcome to 3D Systems Q2 2026 earnings conference call. With me on today's call are Dr. Jeffrey Graves, President and CEO, and Phyllis Nordstrom, Chief Financial Officer. The webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so on the investor relations section of our website.
The following discussion and responses to your questions reflect management's views as of today only and will include forward-looking statements as described on this slide. Actual results may differ materially. Additional information about factors that could potentially impact our financial results is included in our latest press release and our filings with the SEC, including our most recent annual report on Form 10-K and quarterly reports on Form 10-Q.
During this call, we will discuss certain non-GAAP financial measures. In our press release and slides accompanying this webcast, you will find additional disclosures regarding these non-GAAP measures, including reconciliations with comparable GAAP measures. With that, I'll turn the call over to our President and CEO, Dr. Jeffrey Graves, for opening remarks.
Thank you, Monica. Good morning, everyone. Today's call is accompanied by two important announcements: our earnings results and the beginning of a leadership transition plan, both of which I will address this morning. I will begin by reviewing a few important highlights from our Q2 and H1, as well as provide updates on several of our key market focus areas. After that, I'll address this morning's leadership announcement.
I'll then turn the call over to Phyllis Nordstrom, our CFO, who will summarize the quarter's financial results and outlook, and will then open the call up for Q&A. With that, let's turn to slide five. A major theme clearly emerging this year is the return of capital spending by our customers in key markets. The timing is excellent, given the intense focus we've placed on refreshing our product portfolio over the last three years.
In the Q2, printer sales increased by more than 45%, led by our best-selling DMP 350 metal printing system, our new SLA 825 flagship polymer platform, and our MultiJet printing systems that form the cornerstone of our new denture product line.
I'll comment on each of these in the context of their market drivers in a few moments. From a business unit standpoint, our healthcare business once again delivered solid growth and remained the company's largest segment, driven in particular by strong demand for new printing systems in both med tech and dental markets.
Industrial business revenue was modestly lower year-over-year as older systems in our installed base are now being increasingly replaced by our new printer platforms. Despite this dynamic, our two key industrial focus markets, aerospace and defense and data center infrastructure, both delivered strong double-digit growth again this quarter.
I'll share a few highlights on those markets momentarily. Moving to slide six. Our newest generation of 3D printers offer levels of precision, economics, and robustness that were only dreamed of a few years ago. These advancements are now proving essential to the widespread adoption of 3D printing in key production environments. One of the clearest trends is the accelerating use of 3D printing in metal component manufacturing.
As we've discussed on previous calls, there are two equally important paths to producing metal parts. Direct metal printing using laser powder bed fusion and metal castings that rely on 3D-printed patterns as a critical step in the manufacturing process. To address each path, we've launched two important systems. Our DMP 350 triple laser direct metal printer and our SLA 825 dual laser polymer printing system designed for high-quality metal casting patterns.
Sales of both platforms into our key markets have been very strong, with Q2 growth of roughly 90% and 125% respectively year-over-year. Given this rapid rise in demand for 3D-printed metal parts, we're also significantly expanding our internal metal parts production capacity. This is an important element of our growth strategy, and I'll touch on it in more detail in a few moments.
The third breakthrough product we have brought into the market is the NextDent 300, purpose-built for the production of dentures. This platform is being very well received because of its precision and economics, enabling dental professionals to deliver a high-quality, durable product that improves the patient experience while increasing the productivity of their practices. These technologies will continue to enable our success in key markets for years to come. On to slide seven.
As proud as I am of our refreshed product portfolio, it would mean very little if we did not target these systems effectively at markets moving most decisively toward the adoption of additive manufacturing technologies. Four markets fit this profile very clearly. Med tech, dental, aerospace and defense, and data center infrastructure. Two of these sit in our healthcare business and two in our industrial business.
Customers in these markets derive exceptional value from 3D printing, from enhanced design flexibility that improves both performance and cost to reduce supply chain risk in an increasingly volatile world.
With limited time on each quarterly call, I'll focus on a few key use cases that I hope will capture the excitement and momentum these four markets provide. Moving to slide eight, I'll start with aerospace and defense, with a specific focus this quarter on space applications.
Thank you, Jeffrey, and good morning, everyone. Before I begin, Jeffrey, I want to thank you for your leadership over the past six years. Through a period of industry challenges and considerable change, the company made notable progress in strengthening its operational foundation and streamlining its cost structure while also refreshing the product portfolio and sharpening our focus on four important growth markets.
These efforts have established a solid foundation enabling us to build on our strategy moving forward. We are grateful for your continued service to the company during the transition. Thank you very much, Jeffrey. With that, let's now turn to our financial presentation. Before beginning our review, I'd like to remind you that we completed the divestiture of our legacy software businesses during 2025.
As such, the comparisons I will reference today are presented on an adjusted basis, excluding the impact of these divestitures to provide a more meaningful apples-to-apples view of our operating performance across periods. With that, let's now begin on slide 17. As highlighted earlier in the call, our Q2 results reflect continued progress against our strategic priorities. Before I walk through the financial results in more detail, let me start with some highlights from the quarter.
Q2 revenue increased year-over-year, driven by strong demand across our target markets and increasing sales of our new polymer and metal printer platforms. Adjusted EBITDA also improved notably from the prior year period as a result of higher revenue, disciplined cost management, and ongoing operational efficiencies. Turning to our Q2 revenue performance. Revenue was $94.6 million, an increase of 1.4% year-over-year.
This increase was driven by continued momentum in hardware printer sales, which grew over 40% from the prior year period and more than 20% sequentially, as demand across several of our printer platforms continued to strengthen. Performance across our key strategic markets remained strong in the quarter as med tech, aerospace and defense, and data center infrastructure each delivered double digit year-over-year growth.
Within the med tech and aerospace and defense markets, we had strong demand for our DMP 350 metal printers, along with healthy sales of our SLA 825 polymer printer. Both of these platforms meaningfully contributed to revenue performance during the quarter. In data center infrastructure, revenue grew more than 20% year-over-year as a result of increasing demand for metal parts used in critical airflow and thermal management components for semiconductor manufacturing equipment.
Moving now to slide 18 to cover our business segments. Healthcare solutions remained our larger segment in the quarter, with revenue of $48.1 million, up 6.8% from the prior year period. Healthcare growth was driven by continued strength in our med tech market.
Demand for metal printers used by OEMs to produce orthopedic medical implants meaningfully increased during the quarter. Personalized Healthcare Solutions, our PHS business, benefited from growth in surgical planning and trauma applications.
Dental revenue also increased in the quarter, with steady demand for dental material sales and continued adoption of our NextDent 300 denture printer across both the U.S. and Europe. Turning to our industrial segment. Revenue for the Q2 was $46.5 million, down 3.7% from the prior year period and up 2.4% sequentially.
The decline primarily reflected revenue that did not carry forward following the closure of a non-core product offering last year, as well as lower services revenue on our legacy printer installed base. As we continue to see momentum in sales of our updated printer platforms, we believe the ongoing refresh of our installed base should position us to drive future recurring products and services revenue.
Looking across our industrial markets, aerospace and defense remained our largest market, with space and defense applications driving sales in the quarter. We also saw healthy year-over-year growth in data center infrastructure, resulting from increased demand for parts manufacturing, along with solid growth in materials and services revenue within automotive and motorsports. Turning to slide 19 to review gross margin. Q2 non-GAAP gross margin was 36.7%.
Gross margin performance in the quarter reflected offsetting factors, including a higher mix of hardware printer sales, less favorable materials mix, and the comparison to a large regenerative medicine milestone recognized in the prior year period. These headwinds were partially offset by the benefits of prior cost reduction actions and the recognition of $2.6 million in tariff refunds during the quarter.